SlideShare a Scribd company logo
1 of 66
Access, Bottlenecks, Costs, and Equity (ABCE)
Understanding the costs of and constraints to
health service delivery in Ghana
On behalf of the ABCE research team
Institute for Health Metrics and Evaluation | Ghana Health Service | UNICEF
January 2015
Overview
• Overview of the ABCE project in Ghana
• Key findings
o Facility capacity and service provision
o Efficiency and costs of care
• Using ABCE work and findings for
policymaking
• Conclusions
Overview of the ABCE project in Ghana
Overview of the ABCE project in Ghana
ABCE study design and implementation
• Collaboration between
Ghana Health Service
(GHS), UNICEF, and IHME
• Primary data collection
took place June-October
2012.
• The ABCE Facility Survey
was used to collect primary
data from health facilities.
Overview of the ABCE project in Ghana
ABCE Facility Survey
• Primary data collection from a
nationally representative sample
of 240 facilities
• Collected data on a broad range
of indicators
o Inputs, finances, outputs, supply-
side constraints, and bottlenecks
• Randomly sampled a full range of
facility types
o Referral hospitals, district hospitals,
maternity clinics, health centers,
CHPS, drug stores or pharmacies,
and DHMTs
Key findings from the ABCE project in Ghana
Facility capacity and service provision
Facility capacity and service provision
Human resources for health: overall trends
• The average number of facility personnel grew 69% across facilities
in Ghana, from 49 in 2007 to 82 in 2011.
• The most dramatic growth was observed among public hospitals,
followed by private clinics and maternity clinics.
• The average number of internally funded personnel at publicly
owned facilities substantially increased between 2009 and 2011.
Facility capacity and service provision
Average number of facility personnel, 2007–2011
Facility capacity and service provision
Average number of internally funded personnel, 2007–2011
Facility capacity and service provision
Human resources for health: facility composition
• Types of personnel working at facilities substantially varied by
facility type, but non-medical staff generally accounted for the
largest proportion of facility personnel.
• Growth in personnel types varied by platform from 2007 to 2011:
o Regional referral hospitals: the number of nurses or midwives rose 24%
o Public hospitals: non-medical personnel nearly doubled
o Health centers: the average number of nurses or midwives increased 65%.
o CHPS: on average, an additional nurse or midwife was added to each facility.
Facility capacity and service provision
Average percent of personnel type, by platform, 2011
Facility capacity and service provision
Average number and types of personnel, 2007–2011
Facility capacity and service provision
Outputs, 2007–2011
• Most facility types saw gradual growth in both outpatient and
inpatient volumes between 2007 and 2011.
o Private clinics were the exception, recording rapid growth in both outpatient
and inpatient visits.
• These results somewhat contrast with previous reports of quickly
escalating patient volumes across facility types
o Past reports attribute such rapid rises to heightened affiliation with Ghana’s
National Health Insurance Scheme (NHIS).
Facility capacity and service provision
Outputs: average outpatient visits, by platform, 2007–2011
Facility capacity and service provision
Outputs: average inpatient visits, by platform, 2007–2011
Facility capacity and service provision
Drug procurement sources
• Facilities generally obtained pharmaceuticals from a mixture of
private and public sources.
o E.g., over 70% of hospitals used both public and private suppliers to procure
pharmaceuticals.
• The majority of surveyed private clinics, maternity clinics, and
pharmacies reported obtaining all drugs from only private sources.
• Health centers were the only facility type where at least 50% of
facilities reported using only public sources for pharmaceutical
procurement.
Facility capacity and service provision
Average drug procurement source, 2011
Facility capacity and service provision
Availability and stock-outs of antimalarials
• Most facilities stocked some kind of artemisinin-based
combination therapy (ACT) and did not experience stock-outs
during the previous quarter.
o Some facilities still stocked chloroquine, despite policies calling for its
discontinuation.
• Fansidar, the main drug for intermittent preventive therapy during
pregnancy (IPTp), was also widely available for most facilities.
o Compared to other facility types, CHPS and pharmacies generally had
slightly lower availability of ACTs and Fansidar.
• Of the two types of ACTs stocked in Ghana, artemether-
lumefantrine (AL, or Coartem) was generally more available than
artesunate-amodiaquine (AS+AQ).
Facility capacity and service provision
Availability of antimalarials for the previous quarter, 2012
Facility capacity and service provision
Availability of ACTs for the previous quarter, 2012
Facility capacity and service provision
Availability of ACTs and ACT stock-outs for the previous quarter, 2012
Facility capacity and service provision
Capacity to test for and treat malaria
• Facility capacity varied for being able to both diagnose and treat
malaria (i.e., have lab testing or rapid-diagnostic tests [RDTs] and
stock ACTs).
o 100% hospitals, 77% of private clinics, 53% of health centers, 23% of CHPS
• Availability of malaria testing was the primary constraint for most
facility types, with 47% of health centers and 68% of CHPS lacking
malaria diagnostic capacity.
• CHPS and pharmacies experienced a similar proportion of facilities
that lacked both malaria diagnostic capacity and treatment (just
under 10% of facilities).
Facility capacity for service provision
Capacity to test for and treat malaria, 2012
Facility capacity and service provision
Availability and stock-outs of antiretroviral drugs (ARVs)
• Of surveyed facilities, only regional referral hospitals and public
hospitals carried ARVs.
• On average, regional referral hospitals had a higher availability of
ARVs than public hospitals and experienced slightly lower levels of
stock-outs.
• Tenofovir (TDF), nevirapine (NVP), and lamivudine (3TC) were
generally more available at all hospitals, and experienced lower
levels of stock-outs, than efavirenz (EFV) and zidovudine
(AZT/ZDV).
• In terms of stocking all first-line ARVs, 60% of regional referral
hospitals and 33% of public hospitals had all five.
Facility capacity and service provision
Availability of ARVs for the previous quarter, 2012
Facility capacity and service provision
ARV stock-outs for the previous quarter, 2012
Facility capacity and service provision
Diagnostic capacity for a subset of infectious diseases
• Facility capacity to diagnose two infectious diseases that affect
Ghana – malaria and HIV/AIDS – varied by facility type.
• 100% of hospitals had malaria testing capacity, and about 90% of
hospitals had HIV/AIDS testing.
• Facilities generally had a higher availability of malaria testing than
HIV tests; CHPS and maternity clinics were the exceptions.
o 23% of CHPS had malaria tests; 29% had HIV testing
o 50% of maternity clinics had malaria tests; 69% had HIV testing
Facility capacity and service provision
Diagnostic capacity for a subset of infectious diseases
Facility capacity and service provision
Laboratory testing capacity
• Laboratory-based diagnostic capacity varied across facility types
but largely diverged by level of care (hospitals vs. primary care).
• All hospitals had lab capacity for malaria testing and urinalysis, and
over 90% of hospitals had blood draw capacity.
• Primary care facilities had much lower levels of laboratory
capacity, which generally reflects their infrastructure and
organization.
o Privately owned or specialized facilities had much higher availability of lab
testing. Among maternity clinics, for example, 63% of facilities provided
urinalysis, an important component of antenatal care.
Facility capacity and service provision
Laboratory equipment availability for the previous quarter, 2012
Facility capacity and service provision
Vaccine storage capacity and monitoring efficacy
• Of the facilities that routinely stored vaccines, only 64% of facilities had
temperature-monitoring systems in place.
• Among facilities reporting routine vaccine storage, 25% stored vaccines
out of the recommended temperature range (colder than 2° C or warmer
than 8° C).
• The majority of facilities with a temperature-monitoring chart stored
vaccines within the recommended range.
o 90% of hospitals
o 80% of CHPS
o 25% of private clinics
• The majority of facilities that stored vaccines outside of the
recommended temperature range did not have a monitoring chart.
Facility capacity for service provision
Vaccine storage capacity and monitoring efficacy, 2012
Key findings from the ABCE project in Ghana
Efficiency and costs of care
Efficiency and costs of care
Estimating efficiency: Data Envelopment Analysis (DEA)
• DEA: quantifies the relationship between a facility’s resources
(medical staff, beds) and its production of services (outpatient
visits, inpatient bed-days, and births) relative to comparably sized
facilities in the ABCE sample.
• Efficiency score: a value between 0% and 100%, reflecting the
alignment of facility resources to service production.
o 100% = maximum use of facility resources for output production
• Outpatient equivalent visits (OEV): weighting different outputs in a
standardized way to allow for direct comparisons across facilities.
o Average across facilities:
 Inpatient bed-day = 3.8 outpatient visits
 Birth = 10.9 outpatient visits
Efficiency and costs of care
Average production of outputs across facilities
• Across platforms, facilities averaged a total of four outpatient
equivalent visits per medical staff per day, ranging from 2.2 visits
at CHPS to 6.8 visits at maternity clinics.
• Outpatient visits accounted for the largest proportion of patient
visits experienced per medical staff per day at primary care
facilities.
• Inpatient bed-days accounted for the largest proportion of patient
visits produced per medical staff per day at regional referral
hospitals and public hospitals.
Efficiency and costs of care
Average production of outputs across facilities, 2011
Note: All visits are in outpatient equivalent visits, with an average of one inpatient bed-day
equaling 3.8 outpatient visits; and one birth equaling 10.8 outpatient visits.
Efficiency and costs of care
Efficiency scores varied across and within platforms
• Across all facilities, the average efficiency score was 27%.
• More than 80% of facilities had an efficiency score at or less than 50%.
• Average efficiency scores declined in parallel with decreasing levels of
care.
• Private facilities averaged higher efficiency scores than public facilities at
similar levels of care.
• Tremendous range in efficiency scores within platforms:
o At least one facility had an efficiency score of 100% for nearly all platforms.
o Multiple facilities had efficiency scores close to 0% for most facility types.
• Urban facilities generally had higher levels of efficiency than rural
facilities, but this relationship was not as clear-cut at lower levels of care.
Efficiency and costs of care
Efficiency scores across platforms, 2007–2011
Efficiency and costs of care
Estimated potential for expanded service production
• We estimated that facilities had substantial potential for increasing
output production, especially among lower levels of care.
• An average of 13 additional visits, measured in OEV, could be
added across facilities, based on observed resources.
• This potential for expanded service production does not reflect
the quality of services delivered; it shows the alignment of facility
resources and output production.
Efficiency and costs of care
Estimated potential for expanded service production, 2011
Efficiency and costs of care
Cross-country comparison of efficiency
• Ghana showed more potential for expanded service
provision, given observed resources, than other sub-Saharan
African countries involved in the ABCE project.
Efficiency and costs of care
Facility expenditures: overall trends
• Average facility expenditures grew 38%, largely driven by increases
in service and personnel expenditures.
• Hospitals spent the most among facility types, and private clinics
documented the strongest growth between 2007 and 2011.
Efficiency and costs of care
Average annual facility expenditures, 2007–2011
Efficiency and costs of care
Average annual expenditures, 2007–2011
Efficiency and costs of care
Facility expenditures: spending composition
• Spending patterns by facility type were largely similar, with
personnel expenses generally accounting for the bulk of spending
at the facility level.
• Expenditure growth varied by platform from 2007 to 2011:
o Regional referral hospitals: moderate increases, largely driven by service
increases (a 41% rise)
o Public hospitals: overall average expenditures increased 62%
o Health centers: spending on services more than doubled
o CHPS: average spending on personnel increased by 35%, but percent of total
spending on personnel decreased over time
Efficiency and costs of care
Average percent of expenditure type, 2011
Efficiency and costs of care
Average levels and types of expenditures, 2007–2011
Efficiency and costs of care
Facility revenues: overall trends
• Average facility expenditures grew 30% between 2007 and 2011,
largely driven by expanded NHIS reimbursements and continued
growth in government spending.
• Facility revenue growth generally kept pace with spending.
• Private clinics recorded the largest and most consistent increases
in revenues from 2007 to 2011.
Efficiency and costs of care
Average annual facility revenues, 2007–2011
Efficiency and costs of care
Average annual revenues, 2007–2011
Efficiency and costs of care
Facility revenues: funding composition
• Funding patterns by facility type widely varied, largely diverging
along facility ownership (public vs. private).
• Most hospital revenues were composed of government funds and
NHIS reimbursements, whereas publicly owned primary care
facilities were largely funded by the government.
• Revenues at private clinics and maternity clinics were largely
drawn from NHIS or cash and carry.
• Funding trends and composition varied by facility type, but across
a subset of platforms, the overall revenue composition generally
shifted with the expansion of NHIS funds and small declines in
cash and carry.
Efficiency and costs of care
Average percent of revenue source, 2011
Efficiency and costs of care
Average levels and types of revenue sources, 2007–2011
Efficiency and costs of care
Estimating costs of care
• Using information produced through DEA, output-specific
spending by facilities was divided by outputs produced by each
facility.
• All cost data were adjusted for inflation and reported in 2011
Ghanaian cedi.
o All US dollar estimates were based on the 2011 exchange rate of 1.60
cedi per $1.
Efficiency and costs of care
Average facility cost per visit, across outputs and by platform
• Facility costs per patient visit varied across platforms and by
output type.
• Based on average facility costs, outpatient visits were generally the
least expensive to produce, and births were the most expensive.
• Regional referral hospitals generally spent the most per patient
visit produced, whereas maternity clinics generally produced
patient visits at the lowest facility cost per output.
Efficiency and costs of care
Average facility cost per visit, across outputs and by platform
Efficiency and costs of care
Cross-country comparison of output costs
• Ghanaian facilities generally averaged higher production costs
per visit than the other sub-Saharan African countries involved
in the ABCE project.
Using ABCE work and findings for policymaking
Using ABCE for policymaking
Identifying health system progress and challenges
• Provides policymakers with the evidence to pinpoint areas of
success and for improvement as linked to national goals and
priorities
• Enables direct comparisons across facility types and
ownership, allowing policymakers to contrast facility capacity
in the public sector with that of the private sector
• Supports the timely use of data to inform policy dialogue
Using ABCE for policymaking
ABCE Ghana policy report
http://www.healthdata.org/dcpn/ghana
Conclusions
Conclusions
Facility capacity for service provision
• Ghana recorded substantial growth in facility personnel, but composition of staff
varied widely by facility type.
• Facilities generally had a high availability of ACTs for treating malaria, but the
concurrent availability of malaria diagnostics was much lower, particularly
among primary care facilities.
• Hospitals appeared to be the only type of facility that stocked ARVs for HIV
treatment, but HIV testing was generally available across levels of care.
• The majority of facilities in Ghana procured pharmaceuticals from both public
and private sources, which has implications for the country’s regulatory capacity.
• While 25% of facilities that routinely stored vaccines had storage temperatures
outside of the recommended range, the presence of a monitoring chart was
related to better storage practices.
o 90% of facilities with monitoring charts had proper thermal conditions for vaccine storage.
Conclusions
Facility production of health services
• Average patient volumes gradually increased across
platforms, except for private clinics, which recorded rapid
growth.
• Shortages in human resources and facility overcrowding have
been viewed as problems in areas in Ghana; in the ABCE
sample, most facilities averaged fewer than four visits per
medical staff per day.
• Given observed facility resources, facility service production
could potentially be increased by an additional 13 outpatient
equivalent visits per day, on average, per medical staff.
Conclusions
Facility costs of care
• Average facility spending increased over time, often driven by
heightened spending on personnel.
• Growth in facility revenue generally kept pace with spending,
with increased spending by the government and NHIS largely
accounting for growth.
o For a number of facility types, the percentage of facility revenues coming
from cash and carry – or out-of-pocket expenditures – has declined.
• Average facility cost per patient visit differed substantially across
platforms and types of visits.
• In comparison with a subset of other countries in the ABCE
sample, average facility costs in Ghana were generally higher.
Conclusions
Priority considerations for future work
• Updated analyses across indicators to assess progress and to
identify areas that may require more investment
• Targeting a broader set of facilities to capture a clearer picture of
levels and trends in facility performance
• Linking estimates of efficiency to quality of the services produced
at facilities, as well as other factors.
o e.g., expediency with which patients receive care, demand for increased
services
• Generating estimates of cost-effectiveness based on facility
delivery of services and costs of production, and linking to ongoing
work on estimating trends in health outcomes and disease burden
Thank you
http://www.healthdata.org/dcpn/ghana

More Related Content

What's hot

Main Presentation UK Diagnostic Summit 2018
Main Presentation UK Diagnostic Summit 2018Main Presentation UK Diagnostic Summit 2018
Main Presentation UK Diagnostic Summit 2018
Walt Whitman
 
JRM_2014_Report_Final
JRM_2014_Report_FinalJRM_2014_Report_Final
JRM_2014_Report_Final
Asrade Abate
 

What's hot (20)

The power of information: Achieving a national infection management system
The power of information: Achieving a national infection management systemThe power of information: Achieving a national infection management system
The power of information: Achieving a national infection management system
 
Oncology Dynamics - IQVIA
Oncology Dynamics - IQVIAOncology Dynamics - IQVIA
Oncology Dynamics - IQVIA
 
ICNet Global Slides
ICNet Global SlidesICNet Global Slides
ICNet Global Slides
 
Incorporating Patient Preferences Into the HTA Deliberative Framework: The Pa...
Incorporating Patient Preferences Into the HTA Deliberative Framework: The Pa...Incorporating Patient Preferences Into the HTA Deliberative Framework: The Pa...
Incorporating Patient Preferences Into the HTA Deliberative Framework: The Pa...
 
Main Presentation UK Diagnostic Summit 2018
Main Presentation UK Diagnostic Summit 2018Main Presentation UK Diagnostic Summit 2018
Main Presentation UK Diagnostic Summit 2018
 
Pediatric Vasculitis Initiative (PedVas) A CIHR Emerging Team Grant in Rare D...
Pediatric Vasculitis Initiative (PedVas) A CIHR Emerging Team Grant in Rare D...Pediatric Vasculitis Initiative (PedVas) A CIHR Emerging Team Grant in Rare D...
Pediatric Vasculitis Initiative (PedVas) A CIHR Emerging Team Grant in Rare D...
 
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
 
What to expect in AR-DRG Version 10.0
What to expect in AR-DRG Version 10.0What to expect in AR-DRG Version 10.0
What to expect in AR-DRG Version 10.0
 
2016 indicator reference guide viral load suppression at 12 months
2016 indicator reference guide   viral load suppression at 12 months2016 indicator reference guide   viral load suppression at 12 months
2016 indicator reference guide viral load suppression at 12 months
 
Canada’s Orphan Drug Regulatory Framework: What Health Canada is doing now an...
Canada’s Orphan Drug Regulatory Framework: What Health Canada is doing now an...Canada’s Orphan Drug Regulatory Framework: What Health Canada is doing now an...
Canada’s Orphan Drug Regulatory Framework: What Health Canada is doing now an...
 
David page cord standards of care 05 03-2015
David page cord standards of  care 05 03-2015David page cord standards of  care 05 03-2015
David page cord standards of care 05 03-2015
 
STREAM THREE: Jeff Keefer, Inclusion in Clinical Trials
STREAM THREE: Jeff Keefer, Inclusion in Clinical Trials STREAM THREE: Jeff Keefer, Inclusion in Clinical Trials
STREAM THREE: Jeff Keefer, Inclusion in Clinical Trials
 
STREAM ONE: Donna Wall, Bone marrow as a Vehicle for Correction of Rare Disor...
STREAM ONE: Donna Wall, Bone marrow as a Vehicle for Correction of Rare Disor...STREAM ONE: Donna Wall, Bone marrow as a Vehicle for Correction of Rare Disor...
STREAM ONE: Donna Wall, Bone marrow as a Vehicle for Correction of Rare Disor...
 
JRM_2014_Report_Final
JRM_2014_Report_FinalJRM_2014_Report_Final
JRM_2014_Report_Final
 
Advances in Rare Disease Gareth Baynam, Western Australia Health Department (...
Advances in Rare Disease Gareth Baynam, Western Australia Health Department (...Advances in Rare Disease Gareth Baynam, Western Australia Health Department (...
Advances in Rare Disease Gareth Baynam, Western Australia Health Department (...
 
2015 indicator reference guide viral load suppression at 12 months
2015 indicator reference guide   viral load suppression at 12 months2015 indicator reference guide   viral load suppression at 12 months
2015 indicator reference guide viral load suppression at 12 months
 
Barbara Sabourin regulating drugs in canada v2
Barbara Sabourin regulating drugs in canada v2Barbara Sabourin regulating drugs in canada v2
Barbara Sabourin regulating drugs in canada v2
 
Evaluation of the Impact of a Social Support Strategy on Treatment Outcomes
Evaluation of the Impact of a Social Support Strategy on Treatment OutcomesEvaluation of the Impact of a Social Support Strategy on Treatment Outcomes
Evaluation of the Impact of a Social Support Strategy on Treatment Outcomes
 
RWD/RWE for Rare Disease Drugs Webinar
RWD/RWE for Rare Disease Drugs WebinarRWD/RWE for Rare Disease Drugs Webinar
RWD/RWE for Rare Disease Drugs Webinar
 
Day 2: CORD 2021 Fall Conference Slides
Day 2: CORD 2021 Fall Conference SlidesDay 2: CORD 2021 Fall Conference Slides
Day 2: CORD 2021 Fall Conference Slides
 

Similar to Understanding the costs of and constraints to health service delivery in Ghana

Meaningful use stage-1
Meaningful use stage-1Meaningful use stage-1
Meaningful use stage-1
preeti_ipc
 
4 Sally Diagnostics UK May 2016 v3.1.pptx
4 Sally Diagnostics UK May 2016 v3.1.pptx4 Sally Diagnostics UK May 2016 v3.1.pptx
4 Sally Diagnostics UK May 2016 v3.1.pptx
DESMONDEZIEKE1
 
KPI and Outcome Indicators of HWC (1).pptx
KPI and Outcome Indicators of HWC (1).pptxKPI and Outcome Indicators of HWC (1).pptx
KPI and Outcome Indicators of HWC (1).pptx
ddrrrfww
 
Meaningful Use Stage-1
Meaningful Use Stage-1Meaningful Use Stage-1
Meaningful Use Stage-1
preeti_ipc
 

Similar to Understanding the costs of and constraints to health service delivery in Ghana (20)

Managing ACO Populations across the Continuum Financially and Clinically - Do...
Managing ACO Populations across the Continuum Financially and Clinically - Do...Managing ACO Populations across the Continuum Financially and Clinically - Do...
Managing ACO Populations across the Continuum Financially and Clinically - Do...
 
Aine Carroll, National Director of Clinical Strategy & Programmes, HSE
Aine Carroll, National Director of Clinical Strategy & Programmes, HSEAine Carroll, National Director of Clinical Strategy & Programmes, HSE
Aine Carroll, National Director of Clinical Strategy & Programmes, HSE
 
Amarini_BMJ
Amarini_BMJAmarini_BMJ
Amarini_BMJ
 
Story to Sepsis Screen: A Journey in the Details by Elizabeth R. Alpern, MD, ...
Story to Sepsis Screen: A Journey in the Details by Elizabeth R. Alpern, MD, ...Story to Sepsis Screen: A Journey in the Details by Elizabeth R. Alpern, MD, ...
Story to Sepsis Screen: A Journey in the Details by Elizabeth R. Alpern, MD, ...
 
Meaningful use stage-1
Meaningful use stage-1Meaningful use stage-1
Meaningful use stage-1
 
Increasing your Value-Based Purchasing Score through 5 Patient Rounding Best ...
Increasing your Value-Based Purchasing Score through 5 Patient Rounding Best ...Increasing your Value-Based Purchasing Score through 5 Patient Rounding Best ...
Increasing your Value-Based Purchasing Score through 5 Patient Rounding Best ...
 
What is Telehealth, Why Telehealth and Telehealth Demo - Rheuban
What is Telehealth, Why Telehealth and Telehealth Demo - RheubanWhat is Telehealth, Why Telehealth and Telehealth Demo - Rheuban
What is Telehealth, Why Telehealth and Telehealth Demo - Rheuban
 
Operational research to increase the efficiency of ART initiation in Africa
Operational research to increase the efficiency of ART initiation in AfricaOperational research to increase the efficiency of ART initiation in Africa
Operational research to increase the efficiency of ART initiation in Africa
 
Clinical Governance
Clinical GovernanceClinical Governance
Clinical Governance
 
Boldly Using Technology to Change Culture around HIV Testing and Screening…
Boldly Using Technology to Change Culture around HIV Testing and Screening…Boldly Using Technology to Change Culture around HIV Testing and Screening…
Boldly Using Technology to Change Culture around HIV Testing and Screening…
 
IPHS
IPHSIPHS
IPHS
 
4 Sally Diagnostics UK May 2016 v3.1.pptx
4 Sally Diagnostics UK May 2016 v3.1.pptx4 Sally Diagnostics UK May 2016 v3.1.pptx
4 Sally Diagnostics UK May 2016 v3.1.pptx
 
community ebp poster presentation
community ebp poster presentationcommunity ebp poster presentation
community ebp poster presentation
 
7DS Board Assurance Framework: Planning or June 2019 submission
7DS Board Assurance Framework: Planning or June 2019 submission7DS Board Assurance Framework: Planning or June 2019 submission
7DS Board Assurance Framework: Planning or June 2019 submission
 
HealthSPA Oulu Merja Merilainen Telenursing in the Intensive Care Unit
HealthSPA Oulu Merja Merilainen Telenursing in the Intensive Care UnitHealthSPA Oulu Merja Merilainen Telenursing in the Intensive Care Unit
HealthSPA Oulu Merja Merilainen Telenursing in the Intensive Care Unit
 
Claus Duedal's presentation from the Healthcare DENMARK session at HIMSS 2015
Claus Duedal's presentation from the Healthcare DENMARK session at HIMSS 2015Claus Duedal's presentation from the Healthcare DENMARK session at HIMSS 2015
Claus Duedal's presentation from the Healthcare DENMARK session at HIMSS 2015
 
KPI and Outcome Indicators of HWC (1).pptx
KPI and Outcome Indicators of HWC (1).pptxKPI and Outcome Indicators of HWC (1).pptx
KPI and Outcome Indicators of HWC (1).pptx
 
Annual Results and Impact Evaluation Workshop for RBF - Day One - Strengtheni...
Annual Results and Impact Evaluation Workshop for RBF - Day One - Strengtheni...Annual Results and Impact Evaluation Workshop for RBF - Day One - Strengtheni...
Annual Results and Impact Evaluation Workshop for RBF - Day One - Strengtheni...
 
Meaningful Use Stage-1
Meaningful Use Stage-1Meaningful Use Stage-1
Meaningful Use Stage-1
 
Day 1: 2:45pm- 4:00pm Panel Slides (Nov 18) Access to Innovation Conference 2019
Day 1: 2:45pm- 4:00pm Panel Slides (Nov 18) Access to Innovation Conference 2019Day 1: 2:45pm- 4:00pm Panel Slides (Nov 18) Access to Innovation Conference 2019
Day 1: 2:45pm- 4:00pm Panel Slides (Nov 18) Access to Innovation Conference 2019
 

More from Institute for Health Metrics and Evaluation - University of Washington

More from Institute for Health Metrics and Evaluation - University of Washington (20)

Salud Mesoamerica Initiative: Mixed-Methods Evaluation Plan
Salud Mesoamerica Initiative: Mixed-Methods Evaluation PlanSalud Mesoamerica Initiative: Mixed-Methods Evaluation Plan
Salud Mesoamerica Initiative: Mixed-Methods Evaluation Plan
 
Salud Mesoamerica Initiative: Select results from the third operation measure...
Salud Mesoamerica Initiative: Select results from the third operation measure...Salud Mesoamerica Initiative: Select results from the third operation measure...
Salud Mesoamerica Initiative: Select results from the third operation measure...
 
Salud Mesoamerica Process Evaluation: Evidence on Culture Change in Health Sy...
Salud Mesoamerica Process Evaluation: Evidence on Culture Change in Health Sy...Salud Mesoamerica Process Evaluation: Evidence on Culture Change in Health Sy...
Salud Mesoamerica Process Evaluation: Evidence on Culture Change in Health Sy...
 
Salud Mesoamérica Initiative: Mixed-Methods Evaluation Plan
Salud Mesoamérica Initiative: Mixed-Methods Evaluation PlanSalud Mesoamérica Initiative: Mixed-Methods Evaluation Plan
Salud Mesoamérica Initiative: Mixed-Methods Evaluation Plan
 
Salud Mesoamerica Initiative: Select results from the second operation measur...
Salud Mesoamerica Initiative: Select results from the second operation measur...Salud Mesoamerica Initiative: Select results from the second operation measur...
Salud Mesoamerica Initiative: Select results from the second operation measur...
 
Salud Mesoamérica Initiative: Select results from the baseline measurement
Salud Mesoamérica Initiative: Select results from the baseline measurementSalud Mesoamérica Initiative: Select results from the baseline measurement
Salud Mesoamérica Initiative: Select results from the baseline measurement
 
Quality of under-5 mortality statistics in Yucatán, Mexico (Spanish)
Quality of under-5 mortality statistics in Yucatán, Mexico (Spanish)Quality of under-5 mortality statistics in Yucatán, Mexico (Spanish)
Quality of under-5 mortality statistics in Yucatán, Mexico (Spanish)
 
Under-5 mortality and healthcare in Yucatán – 2017 Results dissemination work...
Under-5 mortality and healthcare in Yucatán – 2017 Results dissemination work...Under-5 mortality and healthcare in Yucatán – 2017 Results dissemination work...
Under-5 mortality and healthcare in Yucatán – 2017 Results dissemination work...
 
Under-5 mortality and healthcare in Yucatán – 2021 Results dissemination work...
Under-5 mortality and healthcare in Yucatán – 2021 Results dissemination work...Under-5 mortality and healthcare in Yucatán – 2021 Results dissemination work...
Under-5 mortality and healthcare in Yucatán – 2021 Results dissemination work...
 
The Global Fund Prospective Country Evaluation
The Global Fund Prospective Country EvaluationThe Global Fund Prospective Country Evaluation
The Global Fund Prospective Country Evaluation
 
Prospective Country Evaluation 2019 Synthesis Findings
Prospective Country Evaluation 2019 Synthesis FindingsProspective Country Evaluation 2019 Synthesis Findings
Prospective Country Evaluation 2019 Synthesis Findings
 
Global Burden of Disease (GBD) 2017 study findings
Global Burden of Disease (GBD) 2017 study findingsGlobal Burden of Disease (GBD) 2017 study findings
Global Burden of Disease (GBD) 2017 study findings
 
Expected Human Capital: Key themes and talking points
Expected Human Capital: Key themes and talking pointsExpected Human Capital: Key themes and talking points
Expected Human Capital: Key themes and talking points
 
Global Health Financing
Global Health FinancingGlobal Health Financing
Global Health Financing
 
Maternal and Child Mortality in the United States
Maternal and Child Mortality in the United StatesMaternal and Child Mortality in the United States
Maternal and Child Mortality in the United States
 
Chronic diseases and their risk factors in the Kingdom of Saudi Arabia
Chronic diseases and their risk factors in the Kingdom of Saudi ArabiaChronic diseases and their risk factors in the Kingdom of Saudi Arabia
Chronic diseases and their risk factors in the Kingdom of Saudi Arabia
 
Speyer communicating dataforimpact_2015
Speyer communicating dataforimpact_2015Speyer communicating dataforimpact_2015
Speyer communicating dataforimpact_2015
 
Vital Records: Vital input for population health measurement
Vital Records: Vital input for population health measurementVital Records: Vital input for population health measurement
Vital Records: Vital input for population health measurement
 
Using maps and spatial analysis to inform global health decision making
Using maps and spatial analysis to inform global health decision makingUsing maps and spatial analysis to inform global health decision making
Using maps and spatial analysis to inform global health decision making
 
Open Goverment Data: Insights from the International Open Goverment Data Conf...
Open Goverment Data: Insights from the International Open Goverment Data Conf...Open Goverment Data: Insights from the International Open Goverment Data Conf...
Open Goverment Data: Insights from the International Open Goverment Data Conf...
 

Recently uploaded

Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
mahaiklolahd
 
Russian Call Girls Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service...
Russian Call Girls Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service...Russian Call Girls Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service...
Russian Call Girls Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service...
adilkhan87451
 

Recently uploaded (20)

Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
 
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
 
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
 
Call Girls Shimla Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Shimla Just Call 8617370543 Top Class Call Girl Service AvailableCall Girls Shimla Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Shimla Just Call 8617370543 Top Class Call Girl Service Available
 
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
 
Call Girls Visakhapatnam Just Call 8250077686 Top Class Call Girl Service Ava...
Call Girls Visakhapatnam Just Call 8250077686 Top Class Call Girl Service Ava...Call Girls Visakhapatnam Just Call 8250077686 Top Class Call Girl Service Ava...
Call Girls Visakhapatnam Just Call 8250077686 Top Class Call Girl Service Ava...
 
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
 
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated  Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...Top Rated  Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
 
Top Rated Hyderabad Call Girls Chintal ⟟ 9332606886 ⟟ Call Me For Genuine Se...
Top Rated  Hyderabad Call Girls Chintal ⟟ 9332606886 ⟟ Call Me For Genuine Se...Top Rated  Hyderabad Call Girls Chintal ⟟ 9332606886 ⟟ Call Me For Genuine Se...
Top Rated Hyderabad Call Girls Chintal ⟟ 9332606886 ⟟ Call Me For Genuine Se...
 
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
 
Top Rated Bangalore Call Girls Mg Road ⟟ 9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Mg Road ⟟   9332606886 ⟟ Call Me For Genuine S...Top Rated Bangalore Call Girls Mg Road ⟟   9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Mg Road ⟟ 9332606886 ⟟ Call Me For Genuine S...
 
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
 
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 9332606886 ⟟ Call Me For G...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟  9332606886 ⟟ Call Me For G...Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟  9332606886 ⟟ Call Me For G...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 9332606886 ⟟ Call Me For G...
 
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
 
Call Girls Vadodara Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Vadodara Just Call 8617370543 Top Class Call Girl Service AvailableCall Girls Vadodara Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Vadodara Just Call 8617370543 Top Class Call Girl Service Available
 
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
 
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
 
Russian Call Girls Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service...
Russian Call Girls Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service...Russian Call Girls Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service...
Russian Call Girls Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service...
 
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeTop Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
 
Top Rated Bangalore Call Girls Majestic ⟟ 9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Majestic ⟟  9332606886 ⟟ Call Me For Genuine S...Top Rated Bangalore Call Girls Majestic ⟟  9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Majestic ⟟ 9332606886 ⟟ Call Me For Genuine S...
 

Understanding the costs of and constraints to health service delivery in Ghana

  • 1. Access, Bottlenecks, Costs, and Equity (ABCE) Understanding the costs of and constraints to health service delivery in Ghana On behalf of the ABCE research team Institute for Health Metrics and Evaluation | Ghana Health Service | UNICEF January 2015
  • 2. Overview • Overview of the ABCE project in Ghana • Key findings o Facility capacity and service provision o Efficiency and costs of care • Using ABCE work and findings for policymaking • Conclusions
  • 3. Overview of the ABCE project in Ghana
  • 4. Overview of the ABCE project in Ghana ABCE study design and implementation • Collaboration between Ghana Health Service (GHS), UNICEF, and IHME • Primary data collection took place June-October 2012. • The ABCE Facility Survey was used to collect primary data from health facilities.
  • 5. Overview of the ABCE project in Ghana ABCE Facility Survey • Primary data collection from a nationally representative sample of 240 facilities • Collected data on a broad range of indicators o Inputs, finances, outputs, supply- side constraints, and bottlenecks • Randomly sampled a full range of facility types o Referral hospitals, district hospitals, maternity clinics, health centers, CHPS, drug stores or pharmacies, and DHMTs
  • 6. Key findings from the ABCE project in Ghana Facility capacity and service provision
  • 7. Facility capacity and service provision Human resources for health: overall trends • The average number of facility personnel grew 69% across facilities in Ghana, from 49 in 2007 to 82 in 2011. • The most dramatic growth was observed among public hospitals, followed by private clinics and maternity clinics. • The average number of internally funded personnel at publicly owned facilities substantially increased between 2009 and 2011.
  • 8. Facility capacity and service provision Average number of facility personnel, 2007–2011
  • 9. Facility capacity and service provision Average number of internally funded personnel, 2007–2011
  • 10. Facility capacity and service provision Human resources for health: facility composition • Types of personnel working at facilities substantially varied by facility type, but non-medical staff generally accounted for the largest proportion of facility personnel. • Growth in personnel types varied by platform from 2007 to 2011: o Regional referral hospitals: the number of nurses or midwives rose 24% o Public hospitals: non-medical personnel nearly doubled o Health centers: the average number of nurses or midwives increased 65%. o CHPS: on average, an additional nurse or midwife was added to each facility.
  • 11. Facility capacity and service provision Average percent of personnel type, by platform, 2011
  • 12. Facility capacity and service provision Average number and types of personnel, 2007–2011
  • 13. Facility capacity and service provision Outputs, 2007–2011 • Most facility types saw gradual growth in both outpatient and inpatient volumes between 2007 and 2011. o Private clinics were the exception, recording rapid growth in both outpatient and inpatient visits. • These results somewhat contrast with previous reports of quickly escalating patient volumes across facility types o Past reports attribute such rapid rises to heightened affiliation with Ghana’s National Health Insurance Scheme (NHIS).
  • 14. Facility capacity and service provision Outputs: average outpatient visits, by platform, 2007–2011
  • 15. Facility capacity and service provision Outputs: average inpatient visits, by platform, 2007–2011
  • 16. Facility capacity and service provision Drug procurement sources • Facilities generally obtained pharmaceuticals from a mixture of private and public sources. o E.g., over 70% of hospitals used both public and private suppliers to procure pharmaceuticals. • The majority of surveyed private clinics, maternity clinics, and pharmacies reported obtaining all drugs from only private sources. • Health centers were the only facility type where at least 50% of facilities reported using only public sources for pharmaceutical procurement.
  • 17. Facility capacity and service provision Average drug procurement source, 2011
  • 18. Facility capacity and service provision Availability and stock-outs of antimalarials • Most facilities stocked some kind of artemisinin-based combination therapy (ACT) and did not experience stock-outs during the previous quarter. o Some facilities still stocked chloroquine, despite policies calling for its discontinuation. • Fansidar, the main drug for intermittent preventive therapy during pregnancy (IPTp), was also widely available for most facilities. o Compared to other facility types, CHPS and pharmacies generally had slightly lower availability of ACTs and Fansidar. • Of the two types of ACTs stocked in Ghana, artemether- lumefantrine (AL, or Coartem) was generally more available than artesunate-amodiaquine (AS+AQ).
  • 19. Facility capacity and service provision Availability of antimalarials for the previous quarter, 2012
  • 20. Facility capacity and service provision Availability of ACTs for the previous quarter, 2012
  • 21. Facility capacity and service provision Availability of ACTs and ACT stock-outs for the previous quarter, 2012
  • 22. Facility capacity and service provision Capacity to test for and treat malaria • Facility capacity varied for being able to both diagnose and treat malaria (i.e., have lab testing or rapid-diagnostic tests [RDTs] and stock ACTs). o 100% hospitals, 77% of private clinics, 53% of health centers, 23% of CHPS • Availability of malaria testing was the primary constraint for most facility types, with 47% of health centers and 68% of CHPS lacking malaria diagnostic capacity. • CHPS and pharmacies experienced a similar proportion of facilities that lacked both malaria diagnostic capacity and treatment (just under 10% of facilities).
  • 23. Facility capacity for service provision Capacity to test for and treat malaria, 2012
  • 24. Facility capacity and service provision Availability and stock-outs of antiretroviral drugs (ARVs) • Of surveyed facilities, only regional referral hospitals and public hospitals carried ARVs. • On average, regional referral hospitals had a higher availability of ARVs than public hospitals and experienced slightly lower levels of stock-outs. • Tenofovir (TDF), nevirapine (NVP), and lamivudine (3TC) were generally more available at all hospitals, and experienced lower levels of stock-outs, than efavirenz (EFV) and zidovudine (AZT/ZDV). • In terms of stocking all first-line ARVs, 60% of regional referral hospitals and 33% of public hospitals had all five.
  • 25. Facility capacity and service provision Availability of ARVs for the previous quarter, 2012
  • 26. Facility capacity and service provision ARV stock-outs for the previous quarter, 2012
  • 27. Facility capacity and service provision Diagnostic capacity for a subset of infectious diseases • Facility capacity to diagnose two infectious diseases that affect Ghana – malaria and HIV/AIDS – varied by facility type. • 100% of hospitals had malaria testing capacity, and about 90% of hospitals had HIV/AIDS testing. • Facilities generally had a higher availability of malaria testing than HIV tests; CHPS and maternity clinics were the exceptions. o 23% of CHPS had malaria tests; 29% had HIV testing o 50% of maternity clinics had malaria tests; 69% had HIV testing
  • 28. Facility capacity and service provision Diagnostic capacity for a subset of infectious diseases
  • 29. Facility capacity and service provision Laboratory testing capacity • Laboratory-based diagnostic capacity varied across facility types but largely diverged by level of care (hospitals vs. primary care). • All hospitals had lab capacity for malaria testing and urinalysis, and over 90% of hospitals had blood draw capacity. • Primary care facilities had much lower levels of laboratory capacity, which generally reflects their infrastructure and organization. o Privately owned or specialized facilities had much higher availability of lab testing. Among maternity clinics, for example, 63% of facilities provided urinalysis, an important component of antenatal care.
  • 30. Facility capacity and service provision Laboratory equipment availability for the previous quarter, 2012
  • 31. Facility capacity and service provision Vaccine storage capacity and monitoring efficacy • Of the facilities that routinely stored vaccines, only 64% of facilities had temperature-monitoring systems in place. • Among facilities reporting routine vaccine storage, 25% stored vaccines out of the recommended temperature range (colder than 2° C or warmer than 8° C). • The majority of facilities with a temperature-monitoring chart stored vaccines within the recommended range. o 90% of hospitals o 80% of CHPS o 25% of private clinics • The majority of facilities that stored vaccines outside of the recommended temperature range did not have a monitoring chart.
  • 32. Facility capacity for service provision Vaccine storage capacity and monitoring efficacy, 2012
  • 33. Key findings from the ABCE project in Ghana Efficiency and costs of care
  • 34. Efficiency and costs of care Estimating efficiency: Data Envelopment Analysis (DEA) • DEA: quantifies the relationship between a facility’s resources (medical staff, beds) and its production of services (outpatient visits, inpatient bed-days, and births) relative to comparably sized facilities in the ABCE sample. • Efficiency score: a value between 0% and 100%, reflecting the alignment of facility resources to service production. o 100% = maximum use of facility resources for output production • Outpatient equivalent visits (OEV): weighting different outputs in a standardized way to allow for direct comparisons across facilities. o Average across facilities:  Inpatient bed-day = 3.8 outpatient visits  Birth = 10.9 outpatient visits
  • 35. Efficiency and costs of care Average production of outputs across facilities • Across platforms, facilities averaged a total of four outpatient equivalent visits per medical staff per day, ranging from 2.2 visits at CHPS to 6.8 visits at maternity clinics. • Outpatient visits accounted for the largest proportion of patient visits experienced per medical staff per day at primary care facilities. • Inpatient bed-days accounted for the largest proportion of patient visits produced per medical staff per day at regional referral hospitals and public hospitals.
  • 36. Efficiency and costs of care Average production of outputs across facilities, 2011 Note: All visits are in outpatient equivalent visits, with an average of one inpatient bed-day equaling 3.8 outpatient visits; and one birth equaling 10.8 outpatient visits.
  • 37. Efficiency and costs of care Efficiency scores varied across and within platforms • Across all facilities, the average efficiency score was 27%. • More than 80% of facilities had an efficiency score at or less than 50%. • Average efficiency scores declined in parallel with decreasing levels of care. • Private facilities averaged higher efficiency scores than public facilities at similar levels of care. • Tremendous range in efficiency scores within platforms: o At least one facility had an efficiency score of 100% for nearly all platforms. o Multiple facilities had efficiency scores close to 0% for most facility types. • Urban facilities generally had higher levels of efficiency than rural facilities, but this relationship was not as clear-cut at lower levels of care.
  • 38. Efficiency and costs of care Efficiency scores across platforms, 2007–2011
  • 39. Efficiency and costs of care Estimated potential for expanded service production • We estimated that facilities had substantial potential for increasing output production, especially among lower levels of care. • An average of 13 additional visits, measured in OEV, could be added across facilities, based on observed resources. • This potential for expanded service production does not reflect the quality of services delivered; it shows the alignment of facility resources and output production.
  • 40. Efficiency and costs of care Estimated potential for expanded service production, 2011
  • 41. Efficiency and costs of care Cross-country comparison of efficiency • Ghana showed more potential for expanded service provision, given observed resources, than other sub-Saharan African countries involved in the ABCE project.
  • 42. Efficiency and costs of care Facility expenditures: overall trends • Average facility expenditures grew 38%, largely driven by increases in service and personnel expenditures. • Hospitals spent the most among facility types, and private clinics documented the strongest growth between 2007 and 2011.
  • 43. Efficiency and costs of care Average annual facility expenditures, 2007–2011
  • 44. Efficiency and costs of care Average annual expenditures, 2007–2011
  • 45. Efficiency and costs of care Facility expenditures: spending composition • Spending patterns by facility type were largely similar, with personnel expenses generally accounting for the bulk of spending at the facility level. • Expenditure growth varied by platform from 2007 to 2011: o Regional referral hospitals: moderate increases, largely driven by service increases (a 41% rise) o Public hospitals: overall average expenditures increased 62% o Health centers: spending on services more than doubled o CHPS: average spending on personnel increased by 35%, but percent of total spending on personnel decreased over time
  • 46. Efficiency and costs of care Average percent of expenditure type, 2011
  • 47. Efficiency and costs of care Average levels and types of expenditures, 2007–2011
  • 48. Efficiency and costs of care Facility revenues: overall trends • Average facility expenditures grew 30% between 2007 and 2011, largely driven by expanded NHIS reimbursements and continued growth in government spending. • Facility revenue growth generally kept pace with spending. • Private clinics recorded the largest and most consistent increases in revenues from 2007 to 2011.
  • 49. Efficiency and costs of care Average annual facility revenues, 2007–2011
  • 50. Efficiency and costs of care Average annual revenues, 2007–2011
  • 51. Efficiency and costs of care Facility revenues: funding composition • Funding patterns by facility type widely varied, largely diverging along facility ownership (public vs. private). • Most hospital revenues were composed of government funds and NHIS reimbursements, whereas publicly owned primary care facilities were largely funded by the government. • Revenues at private clinics and maternity clinics were largely drawn from NHIS or cash and carry. • Funding trends and composition varied by facility type, but across a subset of platforms, the overall revenue composition generally shifted with the expansion of NHIS funds and small declines in cash and carry.
  • 52. Efficiency and costs of care Average percent of revenue source, 2011
  • 53. Efficiency and costs of care Average levels and types of revenue sources, 2007–2011
  • 54. Efficiency and costs of care Estimating costs of care • Using information produced through DEA, output-specific spending by facilities was divided by outputs produced by each facility. • All cost data were adjusted for inflation and reported in 2011 Ghanaian cedi. o All US dollar estimates were based on the 2011 exchange rate of 1.60 cedi per $1.
  • 55. Efficiency and costs of care Average facility cost per visit, across outputs and by platform • Facility costs per patient visit varied across platforms and by output type. • Based on average facility costs, outpatient visits were generally the least expensive to produce, and births were the most expensive. • Regional referral hospitals generally spent the most per patient visit produced, whereas maternity clinics generally produced patient visits at the lowest facility cost per output.
  • 56. Efficiency and costs of care Average facility cost per visit, across outputs and by platform
  • 57. Efficiency and costs of care Cross-country comparison of output costs • Ghanaian facilities generally averaged higher production costs per visit than the other sub-Saharan African countries involved in the ABCE project.
  • 58. Using ABCE work and findings for policymaking
  • 59. Using ABCE for policymaking Identifying health system progress and challenges • Provides policymakers with the evidence to pinpoint areas of success and for improvement as linked to national goals and priorities • Enables direct comparisons across facility types and ownership, allowing policymakers to contrast facility capacity in the public sector with that of the private sector • Supports the timely use of data to inform policy dialogue
  • 60. Using ABCE for policymaking ABCE Ghana policy report http://www.healthdata.org/dcpn/ghana
  • 62. Conclusions Facility capacity for service provision • Ghana recorded substantial growth in facility personnel, but composition of staff varied widely by facility type. • Facilities generally had a high availability of ACTs for treating malaria, but the concurrent availability of malaria diagnostics was much lower, particularly among primary care facilities. • Hospitals appeared to be the only type of facility that stocked ARVs for HIV treatment, but HIV testing was generally available across levels of care. • The majority of facilities in Ghana procured pharmaceuticals from both public and private sources, which has implications for the country’s regulatory capacity. • While 25% of facilities that routinely stored vaccines had storage temperatures outside of the recommended range, the presence of a monitoring chart was related to better storage practices. o 90% of facilities with monitoring charts had proper thermal conditions for vaccine storage.
  • 63. Conclusions Facility production of health services • Average patient volumes gradually increased across platforms, except for private clinics, which recorded rapid growth. • Shortages in human resources and facility overcrowding have been viewed as problems in areas in Ghana; in the ABCE sample, most facilities averaged fewer than four visits per medical staff per day. • Given observed facility resources, facility service production could potentially be increased by an additional 13 outpatient equivalent visits per day, on average, per medical staff.
  • 64. Conclusions Facility costs of care • Average facility spending increased over time, often driven by heightened spending on personnel. • Growth in facility revenue generally kept pace with spending, with increased spending by the government and NHIS largely accounting for growth. o For a number of facility types, the percentage of facility revenues coming from cash and carry – or out-of-pocket expenditures – has declined. • Average facility cost per patient visit differed substantially across platforms and types of visits. • In comparison with a subset of other countries in the ABCE sample, average facility costs in Ghana were generally higher.
  • 65. Conclusions Priority considerations for future work • Updated analyses across indicators to assess progress and to identify areas that may require more investment • Targeting a broader set of facilities to capture a clearer picture of levels and trends in facility performance • Linking estimates of efficiency to quality of the services produced at facilities, as well as other factors. o e.g., expediency with which patients receive care, demand for increased services • Generating estimates of cost-effectiveness based on facility delivery of services and costs of production, and linking to ongoing work on estimating trends in health outcomes and disease burden

Editor's Notes

  1. Additional notes: - Average across all facilities: 27% - Each circle represents a facility and its efficiency score for a year between 2007 and 2011. The green vertical bar reflects the average across all facilities and years within a platform.
  2. Additional notes: - All visits are in outpatient equivalent visits, with an average of one inpatient bed-day equaling 3.8 outpatient visits; and one birth equaling 10.9 outpatient visits. - We estimated that, on average, facilities could produce an additional 13 outpatient equivalent visits, per facility, based on resources observed in 2011.
  3. \
  4. These data are for 2011
  5. These data are for 2011
  6. Additional notes: - The final Ghana report released in January 2015 largely draws from the preliminary report presented at the 2013 Ghana Health Summit. Since 2013, efficiency and costs per output analyses were added.